Williams D
Department of Clinical Engineering, University of Liverpool.
Med Device Technol. 2001 Nov;12(9):12-4.
Tissue engineering, xenotransplantation, gene and cell therapy and other emerging products and processes are altering the way in which risks can be assessed and are bringing new challenges to product demarcation.
